365 related articles for article (PubMed ID: 12558280)
1. Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.
Avan P; Bonfils P; Gilain L; Mom T
J Acoust Soc Am; 2003 Jan; 113(1):430-41. PubMed ID: 12558280
[TBL] [Abstract][Full Text] [Related]
2. CD1 hearing-impaired mice. II. Group latencies and optimal f2/f1 ratios of distortion product otoacoustic emissions, and scanning electron microscopy.
Le Calvez S; Guilhaume A; Romand R; Aran JM; Avan P
Hear Res; 1998 Jun; 120(1-2):51-61. PubMed ID: 9667430
[TBL] [Abstract][Full Text] [Related]
3. Evidence for two discrete sources of 2f1-f2 distortion-product otoacoustic emission in rabbit. II: Differential physiological vulnerability.
Whitehead ML; Lonsbury-Martin BL; Martin GK
J Acoust Soc Am; 1992 Nov; 92(5):2662-82. PubMed ID: 1479129
[TBL] [Abstract][Full Text] [Related]
4. Cochlear compression estimates from measurements of distortion-product otoacoustic emissions.
Neely ST; Gorga MP; Dorn PA
J Acoust Soc Am; 2003 Sep; 114(3):1499-507. PubMed ID: 14514203
[TBL] [Abstract][Full Text] [Related]
5. CD1 hearing-impaired mice. I: Distortion product otoacoustic emission levels, cochlear function and morphology.
Le Calvez S; Avan P; Gilain L; Romand R
Hear Res; 1998 Jun; 120(1-2):37-50. PubMed ID: 9667429
[TBL] [Abstract][Full Text] [Related]
6. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
Nieschalk M; Hustert B; Stoll W
Audiology; 1998; 37(2):83-99. PubMed ID: 9547922
[TBL] [Abstract][Full Text] [Related]
7. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
Moulin A
J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
[TBL] [Abstract][Full Text] [Related]
8. [Transitory evoked and distortion products of otoacoustic emissions in absent auditory evoked potentials].
Schöler C; Schönweiler R; Ptok M
HNO; 1997 Dec; 45(12):1008-15. PubMed ID: 9486382
[TBL] [Abstract][Full Text] [Related]
9. Distortion product otoacoustic emissions and sensorineural hearing loss.
Moulin A; Bera JC; Collet L
Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
[TBL] [Abstract][Full Text] [Related]
10. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
Boege P; Janssen T
J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
[TBL] [Abstract][Full Text] [Related]
11. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of distortion-product otoacoustic emissions in humans to tonal over-exposure: time course of recovery and effects of lowering L2.
Sutton LA; Lonsbury-Martin BL; Martin GK; Whitehead ML
Hear Res; 1994 May; 75(1-2):161-74. PubMed ID: 8071143
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in transiently evoked otoacoustic emissions and distortion product otoacoustic emissions in normal-hearing ears.
Satoh Y; Kanzaki J; O-Uchi T; Yoshihara S
Auris Nasus Larynx; 1998 May; 25(2):121-30. PubMed ID: 9673723
[TBL] [Abstract][Full Text] [Related]
14. Effects of furosemide on distortion product otoacoustic emissions and on neuronal responses in the anteroventral cochlear nucleus.
Rübsamen R; Mills DM; Rubel EW
J Neurophysiol; 1995 Oct; 74(4):1628-38. PubMed ID: 8989399
[TBL] [Abstract][Full Text] [Related]
15. Effects of PMCA2 mutation on DPOAE amplitudes and latencies in deafwaddler mice.
Konrad-Martin D; Norton SJ; Mascher KE; Tempel BL
Hear Res; 2001 Jan; 151(1-2):205-220. PubMed ID: 11124466
[TBL] [Abstract][Full Text] [Related]
16. Differential responses to acoustic damage and furosemide in auditory brainstem and otoacoustic emission measures.
Mills DM
J Acoust Soc Am; 2003 Feb; 113(2):914-24. PubMed ID: 12597185
[TBL] [Abstract][Full Text] [Related]
17. Alternative distortion product otoacoustic emissions and hearing loss in a clinical population.
Lind O
Scand Audiol; 1999; 28(4):257-61. PubMed ID: 10572971
[TBL] [Abstract][Full Text] [Related]
18. Distortion product otoacoustic emissions in the C57BL/6J mouse model of age-related hearing loss.
Parham K
Hear Res; 1997 Oct; 112(1-2):216-34. PubMed ID: 9367243
[TBL] [Abstract][Full Text] [Related]
19. The acoustic two-tone distortions 2f1-f2 and f2-f1 and their possible relation to changes in the operating point of the cochlear amplifier.
Frank G; Kössl M
Hear Res; 1996 Sep; 98(1-2):104-15. PubMed ID: 8880185
[TBL] [Abstract][Full Text] [Related]
20. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
